Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank description Gene Value Type Network Comparison Type Interaction Map Filtered green red network_comparison
Results: HTML CSV LaTeX Showing element 601 to 650 of 7460 in total 
Value Type: Measured
Interaction Map: High confidence

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Filtered\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
151\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
pre-mrna cleavage complex ii protein clp1. [source:swissprot;acc:q92989]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
13050.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
14830.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1780.2\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
sh2 domain containing 3c; novel sh2-containing protein 3; sh2 domain-containing 3c; likely ortholog of mouse cas/hef1-associated signal transducer. [source:refseq;acc:nm\_005489]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
5939.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4578.09\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.29746\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
trans-prenyltransferase; polyprenyl pyrophosphate synthetase. [source:refseq;acc:nm\_014317]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1718.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1498.17\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
220.43\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
udp-glucuronosyltransferase 2b17 precursor, microsomal (ec 2.4.1.17) (udpgt) (c19-steroid specific udp-glucuronosyltransferase). [source:swissprot;acc:o75795]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1729.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2230.13\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.28932\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
152\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
high-mobility group 20b; sox-like transcriptional factor; swi/snf-related matrix-associated actin-dependent regulator of chromatin subfamily e, member 1-related. [source:refseq;acc:nm\_006339]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
6895.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5136.78\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1759.2\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma antigen, family d, 4 isoform 1; mage1 protein; mage-e1 protein; maged4 protein. [source:refseq;acc:nm\_030801]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.29736\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
similar to ribosomal protein, large, p0. [source:sptrembl;acc:q96fq9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
2179.77\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1961.09\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
218.68\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
udp-glucuronosyltransferase 2b11 precursor, microsomal (ec 2.4.1.17) (udpgt). [source:swissprot;acc:o75310]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1729.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2230.13\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.28932\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
153\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
block 23. [source:sptrembl;acc:q8nhw5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
2159.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1943.32\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
216.23\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocellular carcinoma-associated protein hca3. [source:refseq;acc:nm\_138703]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.29736\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, cardiac muscle alpha isoform (myhc-alpha). [source:swissprot;acc:p13533]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
7279.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9035\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1755.4\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
udp-glucuronosyltransferase 2b4 precursor, microsomal (ec 2.4.1.17) (udpgt) (hyodeoxycholic acid) (hlug25) (udpgth-1). [source:swissprot;acc:p06133]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1729.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2230.13\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.28932\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
154\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin-dependent kinases regulatory subunit 1 (cks-1) (sid1334) (pnas-16 / pnas-143). [source:swissprot;acc:p33551]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
2015.09\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2231.05\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
215.96\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
glutamyl aminopeptidase (ec 3.4.11.7) (eap) (aminopeptidase a) (apa) (differentiation antigen gp160). [source:swissprot;acc:q07075]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1729.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2230.13\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.28932\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 3 (mage-3 antigen) (antigen mz2-d). [source:swissprot;acc:p43357]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.29736\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, fetal (myosin heavy chain iib) (myhc-iib). [source:swissprot;acc:q9y623]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
7279.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9035\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1755.4\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
155\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
arsenical pump-driving atpase (ec 3.6.3.16) (arsenite-translocating atpase) (arsenical resistance atpase) (arsenite-transporting atpase) (arsa) (asna-i). [source:swissprot;acc:o43681]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1376.88\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1162.21\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
214.67\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 11 (mage-11 antigen). [source:swissprot;acc:p43364]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.29736\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, perinatal (myhc-perinatal). [source:swissprot;acc:p13535]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
7279.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9035\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1755.4\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
udp-glucuronosyltransferase 2b10 precursor, microsomal (ec 2.4.1.17) (udpgt). [source:swissprot;acc:p36537]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1729.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2230.13\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.28932\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
156\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 2 (mage-2 antigen). [source:swissprot;acc:p43356]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.29736\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
metaxin 1. [source:swissprot;acc:q13505]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
723.368\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
933.395\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
210.027\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, adult 2 (myosin heavy chain iia) (myhc-iia). [source:swissprot;acc:q9ukx2]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7279.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9035\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1755.4\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
udp-glucuronosyltransferase 2b15 precursor, microsomal (ec 2.4.1.17) (udpgt) (udpgth-3) (hlug4). [source:swissprot;acc:p54855]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1729.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2230.13\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.28932\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
157\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocellular carcinoma-associated protein hca1. [source:refseq;acc:nm\_020932]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.29736\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
mannosyl-oligosaccharide 1,2-alpha-mannosidase ib (ec 3.2.1.113) (processing alpha-1,2-mannosidase ib) (alpha-1,2-mannosidase ib) (mannosidase alpha class 1a member 2). [source:swissprot;acc:o60476]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
336.584\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
261.105\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.28908\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, fast skeletal muscle, embryonic (muscle embryonic myosin heavy chain) (smhce). [source:swissprot;acc:p11055]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7279.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9035\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1755.4\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
sirtuin 7; sir2-related protein type 7; sirtuin type 7; sirtuin (silent mating type information regulation 2, s.cerevisiae, homolog) 7; silent mating type information regulation 2, s.cerevisiae, homolog 7; sirtuin silent mating type information regulation 2 homolog 7 (s. cerevisiae). [source:refseq;acc:nm\_016538]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1633\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1843\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
210\vspace{3pt}}\\\cline{1-2}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
158\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l9. [source:swissprot;acc:p32969]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
1894.01\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1685.44\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
208.57\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit-like protein 12.3 (p205) (receptor of activated protein kinase c 1) (rack1) (receptor for activated c kinase). [source:swissprot;acc:p25388]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1649.37\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1283.48\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.28508\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 6 (mage-6 antigen) (mage3b). [source:swissprot;acc:p43360]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.29736\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, adult 1 (myosin heavy chain iix/d) (myhc-iix/d). [source:swissprot;acc:p12882]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
7279.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9035\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1755.4\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
159\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lipocalin-interacting membrane receptor. [source:refseq;acc:nm\_018113]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
574.372\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
734.025\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.27796\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
mto1 protein homolog (cgi-02). [source:swissprot;acc:q9y2z2]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
793.818\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1002.2\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
208.382\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, cardiac muscle beta isoform (myhc-beta). [source:swissprot;acc:p12883]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
7279.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9035\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1755.4\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
necdin. [source:swissprot;acc:q99608]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.29736\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
160\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bystin. [source:swissprot;acc:q13895]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3135.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2930.88\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
204.88\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
dj756n5.1.1 (continues in em:al133324 as dj1161h23.3) (fragment). [source:sptrembl;acc:q9h430]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7279.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9035\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1755.4\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
huntingtin interacting protein c. [source:refseq;acc:nm\_012272]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1296.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1653.74\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.27566\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen d1 (mage-d1 antigen) (neurotrophin receptor-interacting mage homolog) (pro2292). [source:swissprot;acc:q9y5v3]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.29736\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
161\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutamine synthetase (ec 6.3.1.2) (glutamate--ammonia ligase). [source:swissprot;acc:p15104]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1026.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1230.54\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
204.36\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
glycine cleavage system h protein, mitochondrial precursor. [source:swissprot;acc:p23434]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1152.06\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
903.767\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.27473\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen f1 (mage-f1 antigen). [source:swissprot;acc:q9hay2]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.29736\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, extraocular (myhc-eo). [source:swissprot;acc:q9ukx3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
7279.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9035\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1755.4\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
162\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l23 (l17). [source:swissprot;acc:p23131]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1956.36\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1753.85\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.51\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like 2 isoform a; autophagy-related cysteine endopeptidase 2; autophagin 2. [source:refseq;acc:nm\_052936]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
7252.02\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5734.28\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.26468\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
high-mobility group 20a. [source:refseq;acc:nm\_018200]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
6893.53\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5140.14\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1753.39\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma antigen, family b, 6. [source:refseq;acc:nm\_173523]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.29736\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
163\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
likely ortholog of mouse variant polyadenylation protein cstf-64. [source:refseq;acc:nm\_015235]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
13246.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
14976.4\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1729.8\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 4 (mage-4 antigen) (mage-x2) (mage-41). [source:swissprot;acc:p43358]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.29736\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/